The single-dose Janssen vaccine was analyzed in a trial of 39,000 patients.
The single-dose Janssen vaccine was analyzed in a trial of 39,000 patients.
False negatives may be reported due to genetic variations of the virus.
A new report from IQVIA found that national MME dropped 17% from 2019 to 2020.
Initial insights from Healthesystems’ annual industry survey.
Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.
A new report explores how COVID-19 has impacted telemedicine, as well as opportunities for expansion.
Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.
Direct customer exposure is associated with a five-fold risk of infection, while less social distancing in the workplace is tied to depression and anxiety.
COVID-19 claim data through October 5th has been captured and broken down by industry, age, region, and more.
With the pandemic disrupting the healthcare system, how has workers’ comp been impacted?
